Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee approves rewrite of pharmacy rules but removes three compounding distribution lines after stakeholder concerns
Summary
The Idaho Senate Health and Welfare Committee approved a comprehensive rewrite of the Idaho State Board of Pharmacy rule chapter while striking three subparts that governed distribution/labeling of compounded drug products after stakeholder concern and debate about federal guidance and patient access.
The Senate Health and Welfare Committee on an oral vote approved pending changes to the Idaho State Board of Pharmacy rule chapter (IDAPA 24.36.01) but removed three lines of text that governed the distribution and labeling of compounded drug products.
The rule rewrite — part of a broader zero-based review (ZBR) of pharmacy regulations — was presented by Nikki Chopsky, bureau chief for health professions at the Division of Occupational and Professional Licenses and executive officer for the Idaho State Board of Pharmacy. Chopsky told the committee the board reviewed more than 35 changes to the chapter and had engaged pharmacy stakeholders, national associations and the Idaho Medical Association in multiple public meetings and hearings.
"The board did a comprehensive review and made more than 35 changes to this chapter," Chopsky…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
